Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Javier Carmona
AKT Signaling in ERBB2-amplified Breast Cancer
Pharmacology and Therapeutics
Pharmacology
Related publications
Strong EGFR Signaling in Cell Line Models of ERBB2-amplified Breast Cancer Attenuates Response Towards ERBB2-targeting Drugs
Oncogenesis
Cancer Research
Molecular Biology
An Insertion Mutation of ERBB2 Enhances Breast Cancer Cell Growth and Confers Resistance to Lapatinib Through AKT Signaling Pathway
Biology Open
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
Functional Redundancy Between Β1 and Β3 Integrin in Activating the IR/Akt/mTORC1 Signaling Axis to Promote ErbB2-Driven Breast Cancer
Cell Reports
Biochemistry
Genetics
Molecular Biology
Akt Rescue in Cardiomyocytes but Not Breast Cancer Cells After Doxorubicin and Anti-erbB2 Treatment
Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer
Cancer Research
Cancer Research
Oncology
Pristimerin Overcomes Adriamycin Resistance in Breast Cancer Cells Through Suppressing Akt Signaling
Oncology Letters
Cancer Research
Oncology
Wedelolactone Inhibits Breast Cancer-Induced Osteoclastogenesis by Decreasing Akt/mTOR Signaling
International Journal of Oncology
Cancer Research
Oncology
Downregulation of Notch Pathway by a -Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model
Cancer Research
Cancer Research
Oncology
FOXP1 Regulation via the PI3K/Akt/p70S6K Signaling Pathway in Breast Cancer Cells
Oncology Letters
Cancer Research
Oncology
